Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2026

Conditions
Metastatic Pancreatic CancerTerminal Cancer
Interventions
DRUG

Ascorbate

For patients with baseline serum Vitamin C concentration \< 65 μmol/L, intravenous Vitamin C 10 g × 7 days, intravenous Vitamin C 4 g × 7 days, intravenous Vitamin C 2 g × 7 days, followed by continuously 900 mg/day, three times a day, orally. For patients with baseline serum Vitamin C concentration ≥ 65 μmol/L, continuously 900 mg/day, three times a day, orally.

Trial Locations (1)

200032

RECRUITING

Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER